Tobramycin

679 Words2 Pages

Tobramycin (Tobi, Tobrex) is an Aminoglycoside broad-spectrum antibiotic. It is effective against “gram-negative bacillary infections, and infections caused by staphylococci when penicillin or other less toxic drugs are contraindicated.” (Vallerand, Sanoski, & Deglin, 2013, p.131) Tobramycin is commonly inhaled to manage the bacteria Pseudomonas aeruginosa in patients with Cystic fibrosis.

Tobramycin inhibits the growth of bacteria at levels of 30S ribosome. The antibiotic is poorly absorbed from the gastrointestinal tract, however it is absorbed rapidly by intramuscular injection. Peak serum concentration level of Tobramycin is reached within 30-90 minutes following intramuscular injection. The half-life of Tobramycin is 2-4 hours. Studies in pregnant women have proven there is a possible risk to the fetus with the use of Tobramycin, classifying this antibiotic in Pregnancy Category D. Vallerand, Sanoski, & Delgin found Tobramycin crosses the placenta, and poor amounts may enter through breast milk (p.131). The benefits of Tobramycin therapy can overshadow the potential danger.

Tobramycin is effective at reducing growth and reproduction of gram-negative bacteria. The bacteria P. aeruginosa, Klebsiella pneumoniae, Escherichia coli, Proteus, Serratia, Acinetobacter, Staphylococcus aureus are susceptible to Tobramycin. When treating enterococcal infections, which are part of the normal intestinal flora of humans, the addition of penicillin is needed. Tobramycin is used to treat external ocular infections, Urinary tract infection, Pseudomonas infection, Staphylococcus bacteria infection, and Respiratory Tract Infections. To reduce the creation of antibiotic-resistant bacteria, and to maintain the efficiency of Tobramycin, this ...

... middle of paper ...

...f inhaler. Patient must disinfect the parts of the nebulizer by boiling them in water every other day of treatment to stop the spread of germs.

Be sure to take medication exactly as directed and do not stop therapy without speaking to health care provider. The nurse should evaluate the effectiveness of any antibiotic treatment to be sure the infection is going away and not getting worse. Improving of the signs and symptoms of infection should be seen by 5 days.

Works Cited

April Hazard Vallerand, Cynthia A. Sanoski, & Judith Hopfer Deglin (2013). Davis’s drug guide for nurses thirteenth edition. Philadelphia: Robert G. Martone
Mosby, Inc. (2013). Mosby’s dictionary of medicine, nursing & health professions 9th edition. Missouri: Deborah Vogel
PubChem Compound (2014). Tobramycin. Retrieved from http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=36294

Open Document